MYR 4.15
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 49.39 Million MYR | -25.83% |
2022 | 66.59 Million MYR | 16.04% |
2021 | 57.38 Million MYR | 109.74% |
2020 | 27.36 Million MYR | -3.06% |
2019 | 28.22 Million MYR | 18.74% |
2018 | 23.77 Million MYR | 18.06% |
2017 | 20.13 Million MYR | 13.13% |
2016 | 17.79 Million MYR | 22.62% |
2015 | 14.51 Million MYR | 67.84% |
2014 | 8.64 Million MYR | -36.54% |
2013 | 13.62 Million MYR | 16.24% |
2012 | 11.72 Million MYR | 30.92% |
2011 | 8.95 Million MYR | 243.72% |
2010 | 2.6 Million MYR | -80.44% |
2009 | 13.32 Million MYR | 38.76% |
2008 | 9.6 Million MYR | 21.09% |
2007 | 7.92 Million MYR | -13.73% |
2006 | 9.19 Million MYR | -2.6% |
2005 | 9.43 Million MYR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 Q4 | 9.67 Million MYR | -20.52% |
2023 Q3 | 12.16 Million MYR | 2.35% |
2023 FY | 56.51 Million MYR | -15.14% |
2023 Q2 | 11.89 Million MYR | -14.56% |
2023 Q1 | 13.91 Million MYR | 3.02% |
2022 Q1 | 18.41 Million MYR | 48.06% |
2022 Q2 | 16 Million MYR | -13.09% |
2022 Q3 | 17.75 Million MYR | 10.93% |
2022 Q4 | 13.5 Million MYR | -23.89% |
2022 FY | 66.59 Million MYR | 16.04% |
2021 Q1 | 15.06 Million MYR | 4.05% |
2021 Q3 | 17.21 Million MYR | 22.76% |
2021 Q4 | 12.43 Million MYR | -27.77% |
2021 FY | 57.38 Million MYR | 109.74% |
2021 Q2 | 14.02 Million MYR | -6.94% |
2020 Q1 | 2.76 Million MYR | -38.76% |
2020 Q3 | 6.43 Million MYR | 85.99% |
2020 FY | 27.36 Million MYR | -3.06% |
2020 Q4 | 14.48 Million MYR | 124.91% |
2020 Q2 | 3.46 Million MYR | 25.12% |
2019 Q4 | 4.51 Million MYR | -43.81% |
2019 FY | 28.22 Million MYR | 18.74% |
2019 Q3 | 8.04 Million MYR | -14.46% |
2019 Q1 | 5.58 Million MYR | -8.23% |
2019 Q2 | 9.39 Million MYR | 68.32% |
2018 Q2 | 5.54 Million MYR | -12.34% |
2018 FY | 23.77 Million MYR | 18.06% |
2018 Q4 | 6.08 Million MYR | 4.48% |
2018 Q3 | 5.82 Million MYR | 5.09% |
2018 Q1 | 6.32 Million MYR | -5.88% |
2017 Q3 | 4.94 Million MYR | -10.24% |
2017 Q2 | 5.5 Million MYR | 54.14% |
2017 FY | 20.13 Million MYR | 13.13% |
2017 Q1 | 3.57 Million MYR | 3.12% |
2017 Q4 | 6.71 Million MYR | 35.83% |
2016 Q3 | 6.04 Million MYR | -16.5% |
2016 FY | 17.79 Million MYR | 22.62% |
2016 Q4 | 3.46 Million MYR | -42.65% |
2016 Q2 | 7.23 Million MYR | 319.84% |
2016 Q1 | 1.72 Million MYR | -62.88% |
2015 Q2 | 2.34 Million MYR | -56.98% |
2015 Q1 | 5.44 Million MYR | 96.18% |
2015 Q3 | 2.41 Million MYR | 2.99% |
2015 Q4 | 4.64 Million MYR | 92.66% |
2015 FY | 14.51 Million MYR | 67.84% |
2014 Q4 | 2.77 Million MYR | 5.72% |
2014 Q3 | 2.62 Million MYR | -38.27% |
2014 FY | 8.64 Million MYR | -36.54% |
2014 Q2 | 4.25 Million MYR | 664.54% |
2014 Q1 | -753 Thousand MYR | -113.26% |
2013 Q2 | 2.02 Million MYR | 262.24% |
2013 Q3 | 7.43 Million MYR | 266.62% |
2013 Q4 | 5.67 Million MYR | -23.62% |
2013 FY | 13.62 Million MYR | 16.24% |
2013 Q1 | -1.25 Million MYR | -115.78% |
2012 Q3 | 5.69 Million MYR | 4603.31% |
2012 FY | 11.72 Million MYR | 30.92% |
2012 Q1 | -1.77 Million MYR | -129.96% |
2012 Q4 | 7.92 Million MYR | 39.22% |
2012 Q2 | 121 Thousand MYR | 106.82% |
2011 Q1 | 1.65 Million MYR | -36.02% |
2011 Q2 | 218 Thousand MYR | -86.86% |
2011 Q4 | 5.91 Million MYR | 410.09% |
2011 FY | 8.95 Million MYR | 243.72% |
2011 Q3 | 1.16 Million MYR | 432.11% |
2010 FY | 2.6 Million MYR | -80.44% |
2010 Q2 | -972 Thousand MYR | 0.0% |
2010 Q3 | -426 Thousand MYR | 56.17% |
2010 Q4 | 2.59 Million MYR | 708.69% |
2009 Q4 | 4.9 Million MYR | 116.95% |
2009 Q3 | 2.25 Million MYR | 0.0% |
2009 FY | 13.32 Million MYR | 38.76% |
2008 FY | 9.6 Million MYR | 21.09% |
2007 FY | 7.92 Million MYR | -13.73% |
2006 FY | 9.19 Million MYR | -2.6% |
2005 FY | 9.43 Million MYR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Duopharma Biotech Berhad | 80.87 Million MYR | 38.923% |